Teprenone

Teprenone
Systematic (IUPAC) name

(5E,9E,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one
Clinical data
AHFS/Drugs.com	International Drug Names
Identifiers
CAS Registry Number	6809-52-5
ATC code	None
PubChem	CID 5282199
UNII	S8S8451A4O^Y
KEGG	D01827^Y
Chemical data
Formula	C₂₃H₃₈O
Molecular mass	330.547 g/mol
Y (what is this?) (verify)

Teprenone (or geranylgeranylacetone) is a pharmaceutical drug used for the treatment of gastric ulcers.^[1]

In Japan it is sold under the brand name Selbex (セルベックス).

References

↑ Kitahata H, Nozaki J, Kawahito S, Tomino T, Oshita S (September 2008). "Low-dose sevoflurane inhalation enhances late cardioprotection from the anti-ulcer drug geranylgeranylacetone". Anesth. Analg. 107 (3): 755–61. doi:10.1213/ane.0b013e31817f0e61. PMID 18713879.

Drugs for peptic ulcer and GERD/GORD (A02B)

H₂ antagonists ("-tidine")

Prostaglandins (E)/analogues ("-prost-")

Proton-pump inhibitors ("-prazole")

Potassium-competitive acid blockers ("-prazan")

Linaprazan
Revaprazan
Soraprazan
Vonoprazan

Other

See also: Helicobacter pylori eradication protocols

Index of digestion

Description	Anatomy tract glands other Physiology enzymes Development

Disease	Congenital Neoplasms and cancer Inflammatory bowel disease Gluten sensitivity Other Symptoms and signs eponymous Blood tests

Treatment	Procedures Drugs anabolic steroids antacids diarrhoea and infection bile and liver functional gastrointestinal disorders laxatives peptic ulcer and reflux nausea and vomiting other Surgery